The U.S. biotechnology company Colossal Biosciences announced on October 1st its plan to revive the ivory-billed woodpecker by 2025, amidst the ongoing debate about whether this iconic bird species is truly extinct. The ivory-billed woodpecker was once a keystone species in the forests of the southern United States, playing a
Continue reading








